Clinical Trials Directory

Trials / Conditions / Stage IB Non-Small Cell Lung Carcinoma

Stage IB Non-Small Cell Lung Carcinoma

10 registered clinical trials studyying Stage IB Non-Small Cell Lung Carcinoma.

StatusTrialSponsorPhase
TerminatedNivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Ca
NCT03366766
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityPhase 2
CompletedDynamic Perfusion Computed Tomography in Patients With Localized Non-small Cell Lung Cancer
NCT03091816
University of Southern California—
CompletedS1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
NCT02728596
SWOG Cancer Research NetworkN/A
CompletedSABR-ATAC: A Trial of TGF-beta Inhibition and Stereotactic Ablative Radiotherapy for Early Stage Non-small Cel
NCT02581787
Maximilian DiehnPhase 1 / Phase 2
CompletedClinicopathological Characteristics and Prognosis Analysis of Stage IB Non-small Cell Lung Cancer
NCT05979623
Shanghai Zhongshan Hospital—
TerminatedAzacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Under
NCT01886573
National Cancer Institute (NCI)Phase 1
TerminatedPioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer
NCT01342770
National Cancer Institute (NCI)Phase 2
TerminatedAzacitidine and Entinostat in Treating Patients With Stage I Non-Small Cell Lung Cancer That Has Been Removed
NCT01207726
National Cancer Institute (NCI)Phase 2
CompletedA Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable
NCT00963807
National Cancer Institute (NCI)Phase 2
CompletedEF5 in Measuring Tumor Hypoxia in Patients With Stage I-III Non-Small Cell Lung Cancer
NCT02154399
National Cancer Institute (NCI)Phase 2